News
Medical technology company Heartflow said on Friday it was targeting a valuation of up to $1.32 billion in its U.S. initial ...
(Reuters) -Cardiac diagnostic software maker Heartflow said on Friday it was targeting a valuation of up to $1.32 billion in ...
1d
News Nation on MSNUnitedHealth CFO out in latest leadership shake-up
UnitedHealth Group announced an executive swap amid a turbulent era for the company that included its CEO being killed and ...
Bristol Myers partners with Bain Capital to launch a new autoimmune-focused biotech, out-licensing five key immunology assets ...
Bristol Myers Squibb and Bain Capital launch a new biopharma firm focused on autoimmune disease treatments, starting with 5 ...
Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing ...
The company will begin with five potential treatments for autoimmune diseases in-licensed from Bristol Myers Squibb, which ...
We recently compiled a list of 11 Best Undervalued Stocks to Invest in Now. Lincoln National Corporation stands third on our ...
Lincoln National's Q2 beat highlights cost cuts, a Bain Capital stake, and Group Protection growth. Read more for insights on ...
1h
Celtics Wire on MSNWNBA-to-Boston celebrations premature? League pushes back on CT Sun move after Pagliuca deal
Fans celebrating the arrival of the WNBA to the City of Boston might want to temper their expectations in the short term.
Rounding up five deals in the home healthcare sector, which has caught the attention of Accel-KKR, Berkshire Partners, ...
US pharma major Bristol Myers Squibb and Bain Capital announced the creation of a new independent biopharmaceutical company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results